ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Biotech companies at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

72 biotech companies are at ESMO 2026 — 51 presentations on the program and 37 with a booth in the exhibit hall. Most represented: XYone Therapeutics (2 on the program), iNtRON Biotechnology (2 on the program), Calidi Biotherapeutics (2 on the program). 40 of them have their own page in this guide. As of Nov 2, 2026.

All 1,879 organizations at ESMO 2026 →

Tumour type
Top represented
Showing 1–14 of 72 organizations
OrganizationESMO 2026 Attendance
XT
Biotech
Oncology drug developer studying antibody–drug conjugates for cancer treatment.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
15:15–16:00
Poster
Mon Oct 26
12:00–12:45
BiotechExhibitor
South Korean biotech developing bacteriophage and endolysin-based medicines, including phage-derived candidates for colorectal cancer.
Booth
Exhibiting at Booth 1102
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Biotech
Biotechnology company developing cell and viral therapies for cancer.
Poster
Sat Oct 24
12:00–12:45
M
mAbxience
Madrid, Spain
Biotech
Biotechnology company developing and manufacturing biosimilar medicines.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
LEON study: A PK-driven biosimilarity study of MB11 to nivolumab in advanced melanoma
ePoster session 12
Melanoma & skin cancers
Biotech
Biopharmaceutical company developing cancer therapies in Hangzhou, China.
SP
Biotech
Biotechnology company developing cancer therapeutics.
Poster
Fri Oct 23
13:00–15:00
Cell DIVE profiling of BTN1A1-associated spatial TME phenotypes in refractory CRC
ePoster session 22
Gastrointestinal cancers
BiotechExhibitor
Spanish biopharmaceutical company developing and marketing marine-derived cancer medicines, including trabectedin and lurbinectedin.
Booth
Exhibiting at Booth 1066
Satellite
Sat Oct 24
18:30–20:00
PharmaMar - More time for patients: Reframing the course of ES-SCLC
Sponsored session · with San Luigi Gonzaga University Hospital
Lung & thoracic cancers
Biotech
A biotechnology company developing targeted radiotherapies for cancer.
Poster
Fri Oct 23
13:00–15:00
BioNTech
Mainz, Germany
BiotechExhibitor
German biotech developing mRNA cancer immunotherapies, antibody-drug conjugates and bispecific antibodies.
Booth
Exhibiting at Booth 8070
Poster
Fri Oct 23
15:15–16:00
BiotechExhibitor
US biotech developing targeted cancer therapies, including antibody-drug conjugates and a gamma secretase inhibitor for desmoid tumours.
Booth
Exhibiting at Booth 8017
Poster
Mon Oct 26
12:00–12:45
Exposure-response (ER) analyses to support the recommended dose of varegacestat (VAR) for patients (pts) with desmoid tumors (DT)
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancers
BiotechExhibitor
Clinical-stage oncology company developing treatments against cancer resistance mechanisms, with programs in prostate and lung cancer.
Booth
Exhibiting at Booth 8103
AIDA Oncology
Copenhagen, Denmark
Biotech
Oncology biotechnology company developing RNA-based tools to predict treatment response and help clinicians select cancer therapies.
Poster
Sun Oct 25
12:00–12:45
Prediction of ADC pay-load: TOP1 predictor development
Sunday Poster Display session 2
Breast cancerBiomarkers & precision oncology
A9
Alpha-9 Oncology
Boston, MA
Biotech
Oncology drug developer studying radioligand therapies for cancer.
Poster
Fri Oct 23
13:00–15:00
A
Alteogen
Daejeon, Republic of Korea
Biotech
Biotechnology company developing medicines, including antibody-drug conjugate technologies.
Poster
Fri Oct 23
13:00–15:00
Berahyaluronidase alfa enables subcutaneous administration of antibody–drug conjugates with improved local and hematologic tolerability
ePoster session 6
Haematological malignanciesBreast cancerMelanoma & skin cancersSarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from biotech companies

Tell us what you sell and we’ll find the people at these biotech companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse ESMO 2026 by

Exhibit hall

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction